Horizon Space Acquisition II Corp. - Ordinary share (HSPT)

New York, NY, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Horizon Space Acquisition II Corp. (the “Company” or “HSPT”) (NASDAQ: HSPT) today announced that it postponed the extraordinary general meeting (the “Extraordinary Meeting”) originally scheduled at 9:00 a.m. Eastern Time, on February 3, 2026, to 9:00 a.m. Eastern Time, on February 12, 2026 (the “Postponement”) to allow the Company additional time to engage with its shareholders.

NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Horizon Space Acquisition II Corp. ("HSPT") (Nasdaq:HSPT), a publicly traded special purpose acquisition company, and SL Bio Ltd. ("SL Bio"), a clinical-stage biomedical company specialized in developing groundbreaking cellular and gene therapies for skin care and cancer recovery, today announced that they have entered into a definitive business combination agreement (the "Business Combination Agreement"). Upon completion of the business combination of HSPT and SL Bio and related transactions pursuant to the Business Combination Agreement (collectively, the "Proposed Transactions"), SL Science Holding Limited, a Cayman Islands exempted company newly formed for purposed of effecting the Proposed Transaction (the "Combined Company" or "PubCo") will be listed on The Nasdaq Stock Market LLC ("Nasdaq").The closing of the Proposed Transactions is subject to customary closing conditions, including regulatory and shareholder approvals.